Singapore markets closed

Nuwellis, Inc. (NUWE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
0.1678-0.1212 (-41.94%)
At close: 04:00PM EDT
0.1700 +0.00 (+1.31%)
After hours: 07:55PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close0.2890
Open0.1599
Bid0.1540 x 100
Ask0.1690 x 300
Day's range0.1461 - 0.1848
52-week range0.1461 - 4.8800
Volume18,260,885
Avg. volume1,274,017
Market cap1.141M
Beta (5Y monthly)0.17
PE ratio (TTM)N/A
EPS (TTM)-11.5200
Earnings date07 May 2024 - 13 May 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est5.25
  • GlobeNewswire

    Nuwellis Announces Pricing of $2.7 Million Public Offering

    MINNEAPOLIS, April 26, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) (“Nuwellis” or the “Company”), a medical technology company focused on transforming the lives of people with fluid overload, today announced the pricing of a public offering of 11,250,000 shares of its common stock (or pre-funded warrants in lieu thereof) and warrants to purchase up to an aggregate of 16,875,000 shares of its common stock at a combined public offering price $0.24 per share (or pre-funded warrant in lie

  • GlobeNewswire

    Nuwellis Announces Launch of Ultrafiltration Therapy Using Aquadex Smartflow® System at Henry Ford Health

    MINNEAPOLIS, April 09, 2024 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE) today announced that Detroit, Michigan-based health system, Henry Ford Health, has begun offering ultrafiltration therapy to heart failure patients suffering from fluid overload using the company’s Aquadex SmartFlow system as part of Nuwellis’ pivotal REVERSE-HF clinical study. “We are excited to study the impact of Aquadex SmartFlow therapy on our heart failure patients who are suffering from severe fluid overload,” s

  • Simply Wall St.

    Nuwellis Full Year 2023 Earnings: EPS Beats Expectations

    Nuwellis ( NASDAQ:NUWE ) Full Year 2023 Results Key Financial Results Revenue: US$8.86m (up 3.8% from FY 2022). Net...